| T-cell invigoration to tumour burden ratio associated with anti-PD-1 response AC Huang, MA Postow, RJ Orlowski, R Mick, B Bengsch, S Manne, W Xu, ... Nature 545 (7652), 60-65, 2017 | 1473 | 2017 |
| Multi-institutional validation study of the American Joint Commission on Cancer changes for T and N staging in patients with pancreatic adenocarcinoma PJ Allen, D Kuk, C Fernandez-del Castillo, O Basturk, CL Wolfgang, ... Annals of surgery 265 (1), 185-191, 2017 | 471 | 2017 |
| Integrated NY-ESO-1 antibody and CD8+ T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab J Yuan, M Adamow, BA Ginsberg, TS Rasalan, E Ritter, HF Gallardo, Y Xu, ... Proceedings of the National Academy of Sciences 108 (40), 16723-16728, 2011 | 396 | 2011 |
| Prevalence of tumor-infiltrating lymphocytes and PD-L1 expression in the soft tissue sarcoma microenvironment SP D’Angelo, AN Shoushtari, NP Agaram, D Kuk, LX Qin, RD Carvajal, ... Human pathology 46 (3), 357-365, 2015 | 305 | 2015 |
| Histology-based classification predicts pattern of recurrence and improves risk stratification in primary retroperitoneal sarcoma MCB Tan, MF Brennan, D Kuk, NP Agaram, CR Antonescu, LX Qin, ... Annals of surgery 263 (3), 593-600, 2016 | 301 | 2016 |
| The efficacy of anti‐PD‐1 agents in acral and mucosal melanoma AN Shoushtari, RR Munhoz, D Kuk, PA Ott, DB Johnson, KK Tsai, ... Cancer 122 (21), 3354-3362, 2016 | 275 | 2016 |
| An international multi-institutional validation of age 55 years as a cutoff for risk stratification in the AJCC/UICC staging system for well-differentiated thyroid cancer IJ Nixon, LY Wang, JC Migliacci, A Eskander, MJ Campbell, A Aniss, ... Thyroid 26 (3), 373-380, 2016 | 227 | 2016 |
| Prognosis of mucosal, uveal, acral, nonacral cutaneous, and unknown primary melanoma from the time of first metastasis D Kuk, AN Shoushtari, CA Barker, KS Panageas, RR Munhoz, P Momtaz, ... The oncologist 21 (7), 848-854, 2016 | 186 | 2016 |
| Dynamic contrast enhanced-MRI for the detection of pathological complete response to neoadjuvant chemotherapy for locally advanced rectal cancer MJ Gollub, DH Gultekin, O Akin, RK Do, JL Fuqua, M Gonen, D Kuk, ... European radiology 22, 821-831, 2012 | 169 | 2012 |
| Associations Between Mutations and Histologic Patterns of Mucin in Lung Adenocarcinoma: Invasive Mucinous Pattern and Extracellular Mucin Are Associated With: KRAS: Mutation K Kadota, YC Yeh, SP D’Angelo, AL Moreira, D Kuk, CS Sima, GJ Riely, ... The American journal of surgical pathology 38 (8), 1118-1127, 2014 | 166 | 2014 |
| Near universal detection of alterations in CTNNB1 and Wnt pathway regulators in desmoid‐type fibromatosis by whole‐exome sequencing and genomic analysis AM Crago, J Chmielecki, M Rosenberg, R O'Connor, C Byrne, FG Wilder, ... Genes, Chromosomes and Cancer 54 (10), 606-615, 2015 | 165 | 2015 |
| Is port site resection necessary in the surgical management of gallbladder cancer? AV Maker, JM Butte, J Oxenberg, D Kuk, M Gonen, Y Fong, RP DeMatteo, ... Annals of surgical oncology 19, 409-417, 2012 | 157 | 2012 |
| Comparison of local recurrence with conventional and intensity-modulated radiation therapy for primary soft-tissue sarcomas of the extremity MR Folkert, S Singer, MF Brennan, D Kuk, LX Qin, WK Kobayashi, ... Journal of Clinical Oncology 32 (29), 3236, 2014 | 156 | 2014 |
| Long-term outcomes following microwave ablation for liver malignancies U Leung, D Kuk, MI D'angelica, TP Kingham, PJ Allen, RP DeMatteo, ... Journal of British Surgery 102 (1), 85-91, 2015 | 142 | 2015 |
| Model selection in competing risks regression D Kuk, R Varadhan Statistics in medicine 32 (18), 3077-3088, 2013 | 141 | 2013 |
| Computational algorithm-driven evaluation of monocytic myeloid-derived suppressor cell frequency for prediction of clinical outcomes S Kitano, MA Postow, CGK Ziegler, D Kuk, KS Panageas, C Cortez, ... Cancer immunology research 2 (8), 812-821, 2014 | 138 | 2014 |
| Pretreatment serum VEGF is associated with clinical response and overall survival in advanced melanoma patients treated with ipilimumab J Yuan, J Zhou, Z Dong, S Tandon, D Kuk, KS Panageas, P Wong, X Wu, ... Cancer immunology research 2 (2), 127-132, 2014 | 137 | 2014 |
| Evaluation of serum IL-17 levels during ipilimumab therapy: Correlation with colitis. MK Callahan, A Yang, S Tandon, Y Xu, SK Subudhi, RA Roman, AI Heine, ... Journal of Clinical Oncology 29 (15_suppl), 2505-2505, 2011 | 137 | 2011 |
| Stage-stratified prognosis of signet ring cell histology in patients undergoing curative resection for gastric adenocarcinoma ZM Bamboat, LH Tang, E Vinuela, D Kuk, M Gonen, MA Shah, ... Annals of surgical oncology 21, 1678-1685, 2014 | 134 | 2014 |
| Defining a valid age cutoff in staging of well-differentiated thyroid cancer IJ Nixon, D Kuk, V Wreesmann, L Morris, FL Palmer, I Ganly, SG Patel, ... Annals of surgical oncology 23, 410-415, 2016 | 113 | 2016 |
